FreeObituary Isaiah Fidler, founder of MD Anderson Department of Cancer Biology, dies at 83 May 15, 2020Vol.46 No.20
COVID-19 & CancerFreeGuest Editorial SARS-CoV-2 and oncology drugsWhat do we mean when we talk about value? May 15, 2020Vol.46 No.20By Garth W. Strohbehn, Daniel A. Goldstein and Mark J. Ratain
Free NCI BSA approves 11 new and reissue concepts, defers one May 15, 2020Vol.46 No.20By Alexandria Carolan
COVID-19 & CancerFreeNCI Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality May 15, 2020Vol.46 No.20By Matthew Bin Han Ong
COVID-19 & CancerFree With $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Nancy Davidson describes plans for reopening the Seattle Cancer Care Alliance as COVID-19 wave recedes May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Lessons from COVID-19:Leaders of six cancer centers in the DMV area tell us about caseloads, the outlook—and impact May 08, 2020Vol.46 No.19By Matthew Bin Han Ong
COVID-19 & CancerFree COVID-19 slams into the nation’s capital region; Here is the damage assessment at six institutions May 08, 2020Vol.46 No.19By Matthew Bin Han Ong
COVID-19 & CancerFree NCI receives $306 million in new money for COVID-19 serology test research;Details to follow at BSA meeting May 12 May 08, 2020Vol.46 No.19By Paul Goldberg
